Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Sonoma Pharmaceuticals Gross Margin 2010-2023 | SNOA

Current and historical gross margin for Sonoma Pharmaceuticals (SNOA) over the last 10 years. The current gross profit margin for Sonoma Pharmaceuticals as of December 31, 2023 is %.
  
Sonoma Pharmaceuticals Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2023-12-31 $0.01B $0.00B 25.00%
2023-09-30 $0.01B $0.00B 25.00%
2023-06-30 $0.01B $0.00B 33.33%
2023-03-31 $0.01B $0.01B 38.46%
2022-12-31 $0.01B $0.01B 41.67%
2022-09-30 $0.01B $0.01B 41.67%
2022-06-30 $0.01B $0.00B 30.77%
2022-03-31 $0.01B $0.00B 23.08%
2021-12-31 $0.01B $0.00B 23.08%
2021-09-30 $0.02B $0.00B 26.67%
2021-06-30 $0.02B $0.01B 35.29%
2021-03-31 $0.02B $0.01B 36.84%
2020-12-31 $0.02B $0.01B 42.86%
2020-09-30 $0.02B $0.01B 45.00%
2020-06-30 $0.02B $0.01B 42.11%
2020-03-31 $0.02B $0.01B 47.06%
2019-12-31 $0.02B $0.01B 47.06%
2019-09-30 $0.02B $0.01B 50.00%
2019-06-30 $0.02B $0.01B 50.00%
2019-03-31 $0.02B $0.01B 50.00%
2018-12-31 $0.02B $0.01B 44.44%
2018-09-30 $0.02B $0.01B 38.89%
2018-06-30 $0.02B $0.01B 41.18%
2018-03-31 $0.02B $0.01B 41.18%
2017-12-31 $0.02B $0.01B 47.06%
2017-09-30 $0.02B $0.01B 53.33%
2017-06-30 $0.01B $0.01B 50.00%
2017-03-31 $0.01B $0.01B 46.15%
2016-12-31 $0.01B $0.00B 25.00%
2016-09-30 $0.01B 0 0.00%
2016-06-30 $0.01B $0.00B 12.50%
2016-03-31 $0.01B $0.00B 22.22%
2015-12-31 $0.01B $0.01B 42.86%
2015-09-30 $0.02B $0.01B 53.33%
2015-06-30 $0.01B $0.01B 57.14%
2015-03-31 $0.01B $0.01B 61.54%
2014-12-31 $0.01B $0.01B 58.33%
2014-09-30 $0.01B $0.01B 58.33%
2014-06-30 $0.01B $0.01B 61.54%
2014-03-31 $0.01B $0.01B 61.54%
2013-12-31 $0.01B $0.01B 69.23%
2013-09-30 $0.01B $0.01B 64.29%
2013-06-30 $0.02B $0.01B 60.00%
2013-03-31 $0.02B $0.01B 62.50%
2012-12-31 $0.02B $0.01B 62.50%
2012-09-30 $0.02B $0.01B 66.67%
2012-06-30 $0.01B $0.01B 71.43%
2012-03-31 $0.01B $0.01B 69.23%
2011-12-31 $0.01B $0.01B 69.23%
2011-09-30 $0.01B $0.01B 66.67%
2011-06-30 $0.01B $0.01B 70.00%
2011-03-31 $0.01B $0.01B 66.67%
2010-12-31 $0.01B $0.01B 62.50%
2010-09-30 $0.01B $0.01B 62.50%
2010-06-30 $0.01B $0.00B 50.00%
2010-03-31 $0.01B $0.00B 50.00%
2009-12-31 $0.01B $0.00B 57.14%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.002B $0.013B
Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.564B 27.36
Chugai Pharmaceutical (CHGCY) Japan $54.745B 23.77
Takeda Pharmaceutical (TAK) Japan $42.282B 6.85
Merck (MKGAF) Germany $20.162B 19.02
Astellas Pharma (ALPMY) Japan $17.246B 24.44
Sandoz Group AG (SDZNY) Switzerland $14.663B 0.00
Shionogi (SGIOY) Japan $14.423B 12.48
Neurocrine Biosciences (NBIX) United States $13.300B 55.23
United Therapeutics (UTHR) United States $11.015B 11.80
Catalent (CTLT) United States $10.144B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.644B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.856B 6.95
Revolution Medicines (RVMD) United States $6.000B 0.00
Ionis Pharmaceuticals (IONS) United States $5.986B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.248B 0.00
Alpine Immune Sciences (ALPN) United States $4.233B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.023B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.964B 0.00
Evotec AG (EVO) Germany $2.608B 0.00
Indivior (INDV) United States $2.556B 11.89
Summit Therapeutics (SMMT) United States $2.449B 0.00
Corcept Therapeutics (CORT) United States $2.321B 23.47
Dyne Therapeutics (DYN) United States $2.143B 0.00
PTC Therapeutics (PTCT) United States $1.990B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.809B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.806B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.783B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.782B 18.42
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.649B 9.76
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.80
Avadel Pharmaceuticals (AVDL) Ireland $1.567B 0.00
Ardelyx (ARDX) United States $1.515B 0.00
4D Molecular Therapeutics (FDMT) United States $1.350B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.262B 11.85
Soleno Therapeutics (SLNO) United States $1.219B 0.00
Pacira BioSciences (PCRX) United States $1.214B 12.08
Collegium Pharmaceutical (COLL) United States $1.136B 6.99
Xencor (XNCR) United States $1.113B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.003B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.909B 0.00
Cronos Group (CRON) Canada $0.902B 0.00
Cassava Sciences (SAVA) United States $0.887B 0.00
USANA Health Sciences (USNA) United States $0.851B 13.40
Enliven Therapeutics (ELVN) United States $0.825B 0.00
ARS Pharmaceuticals (SPRY) United States $0.792B 0.00
Ocular Therapeutix (OCUL) United States $0.785B 0.00
Relay Therapeutics (RLAY) United States $0.781B 0.00
Sage Therapeutics (SAGE) United States $0.775B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.730B 0.00
Silence Therapeutics (SLN) United Kingdom $0.673B 0.00
Savara (SVRA) United States $0.649B 0.00
ProKidney (PROK) United States $0.624B 0.00
Lyell Immunopharma (LYEL) United States $0.612B 0.00
Siga Technologies (SIGA) United States $0.594B 8.79
Verve Therapeutics (VERV) United States $0.578B 0.00
Korro Bio (KRRO) United States $0.549B 0.00
OmniAb (OABI) United States $0.548B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.539B 0.00
Altimmune (ALT) United States $0.530B 0.00
Exscientia (EXAI) United Kingdom $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.483B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.459B 0.00
Lexeo Therapeutics (LXEO) United States $0.417B 0.00
Larimar Therapeutics (LRMR) United States $0.408B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.392B 74.25
Heron Therapeutics (HRTX) United States $0.389B 0.00
Harrow (HROW) United States $0.375B 0.00
Nature's Sunshine Products (NATR) United States $0.365B 20.43
Esperion Therapeutics (ESPR) United States $0.362B 0.00
Bioventus (BVS) United States $0.340B 0.00
Aquestive Therapeutics (AQST) United States $0.321B 0.00
Fractyl Health (GUTS) United States $0.313B 0.00
Lyra Therapeutics (LYRA) United States $0.311B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.285B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.284B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Nanobiotix S.A (NBTX) France $0.270B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Black Diamond Therapeutics (BDTX) United States $0.260B 0.00
Adherex Technologies (FENC) United States $0.254B 0.00
Metagenomi (MGX) United States $0.250B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Acrivon Therapeutics (ACRV) United States $0.215B 0.00
Foghorn Therapeutics (FHTX) United States $0.215B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.211B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.198B 0.00
Century Therapeutics (IPSC) United States $0.198B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Galectin Therapeutics (GALT) United States $0.189B 0.00
Telomir Pharmaceuticals (TELO) United States $0.166B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
MediWound (MDWD) Israel $0.150B 0.00
Incannex Healthcare (IXHL) Australia $0.149B 0.00
CytoDyn (CYDY) United States $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.144B 0.00
Elite Pharmaceuticals (ELTP) United States $0.136B 12.72
VAXART, INC (VXRT) United States $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.83
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
Relmada Therapeutics (RLMD) United States $0.117B 0.00
OptiNose (OPTN) United States $0.116B 0.00
GlycoMimetics (GLYC) United States $0.116B 0.00
Inotiv (NOTV) United States $0.114B 0.00
FibroGen (FGEN) United States $0.113B 0.00
Eliem Therapeutics (ELYM) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.089B 0.00
ProPhase Labs (PRPH) United States $0.088B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.66
Marinus Pharmaceuticals (MRNS) United States $0.081B 0.00
Carisma Therapeutics (CARM) United States $0.078B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.81
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
Nutriband (NTRB) United States $0.028B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.80
MEI Pharma (MEIP) United States $0.022B 1.13
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
Addex Therapeutics (ADXN) Switzerland $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Cosmos Health (COSM) Greece $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.81